Local residents can enroll in CPS-3 online at: www.cps3utah.org
“By joining this study, people can literally help us save lives, giving future generations more time with families and friends, more memories, more celebrations, and more birthdays,” said Zach Smith, CPS-3 Community Lead. Signing up requires a one-time in-person visit to read and sign a consent form, complete a survey, have your waist measured, and give a small non-fasting blood sample like what you’d do during a routine doctor visit. Participants will also complete a more detailed survey at home and will continue to receive periodic follow-up surveys in the future that researchers will use to look for more clues to cancer’s causes.
“Many individuals diagnosed with cancer struggle to answer the question, ‘What caused my cancer?’ In many cases, we don’t know the answer,” said Alpa V. Patel, Ph.D., principal investigator of CPS-3. “CPS-3 will help us better understand what factors cause cancer, and once we know that, we can be better equipped to prevent cancer.”
CPS-3 is the latest addition to the Society’s groundbreaking cancer prevention studies, which have been instrumental in helping identify major factors that can affect cancer risk. Researchers say CPS-3 holds the best hope of identifying new and emerging cancer risks. But its success depends on members of the community becoming involved. Researchers will use data from CPS-3 to build on evidence from those earlier cancer prevention studies, which began in the 1950s and involved hundreds of thousands of volunteer participants.
“Among other findings, these cancer prevention studies have confirmed the link between cigarette smoking and lung cancer, demonstrated the link between larger waist size and increased death rates from cancer and other causes, and showed the considerable impact of air pollution on heart and lung conditions, said Smith. “Changes in lifestyle over the past several decades as well as a better understanding of cancer make this latest chapter in this lifesaving series of studies a critical part of continuing the progress we’re seeing against the disease.”